High-fat diet-induced obesity enhances allograft rejection

Transplantation

Volumn 100, Issue 5, 2016, Pages 1015-1021

  Molinero, Luciana L ^a,b   Yin, Dengping ^a   Lei, Yuk Man ^a   Chen, Luqiu ^a   Wang, Ying ^a   Chong, Anita S ^a   Alegre, Maria Luisa ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCOSE BLOOD LEVEL;

ALLOIMMUNITY; ALLOIMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET INDUCED OBESITY; FLOW CYTOMETRY; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; LIPID DIET; LOW FAT DIET; LYMPHOCYTE FUNCTION; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; ALLOTRANSPLANTATION; ANALYSIS; ANIMAL; BAGG ALBINO MOUSE; BODY WEIGHT; C57BL MOUSE; COMPLICATION; CYTOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; HEART; IMMUNOLOGY; INFLAMMATION; KINETICS; LYMPHOCYTE ACTIVATION; OBESITY; PHYSIOLOGY; RETROSPECTIVE STUDY; SPLEEN; T LYMPHOCYTE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART; HEART TRANSPLANTATION; INFLAMMATION; INTERFERON-GAMMA; KINETICS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OBESITY; PHENOTYPE; RETROSPECTIVE STUDIES; SPLEEN; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84961392516     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001141     Document Type: Article

References (45)

1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl JMed. 2007;356:213-215.
2. Hersoug LG, Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy. 2007;62:1205-1213.
3. Lovren F, Teoh H, Verma S. obesity and atherosclerosis: mechanistic insights. Can J Cardiol. 2015;31:177-183.
4. Kredel LI, Siegmund B. Adipose-tissue and intestinal inflammation-visceral obesity and creeping fat. Front Immunol. 2014;5:462.
5. Zamosky L. The obesity epidemic. While America swallows 147 billion in obesity-related healthcare costs, physicians called on to confront the crisis. Med Econ. 2013;90:14-17.
6. Tian YF, Chang WC, Loh CH, et al. Leptin-mediated inflammatory signaling crucially links visceral fat inflammation to obesity-associated beta-cell dysfunction. Life Sci. 2014;116:51-58.
7. Hill AA, Reid Bolus W, Hasty AH. A decade of progress in adipose tissue macrophage biology. Immunol Rev. 2014;262:134-152.
8. Priceman SJ, KujawskiM, Shen S, et al. Regulation of adipose tissue Tcell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A. 2013;110:13079-13084.
9. Piccio L, Cantoni C, Henderson JG, et al. Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. Eur J Immunol. 2013;43:2089-20100.
10. Paik J, Fierce Y, Treuting PM, et al. High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a?/? male mice. J Nutr. 2013;143:1240-1247.
11. Gruber L, Kisling S, Lichti P, et al. High fat Diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity. PLoS One. 2013;8:e71661.
12. Yamamoto S, Hanley E, Hahn AB, et al. The impact of obesity in renal transplantation: an analysis of paired cadaver kidneys. Clin Transplant. 2002;16:252-256.
13. Flancbaum L, Choban PS. Surgical implications of obesity. Annu Rev Med. 1998;49:215-234.
14. Weissenbacher A, Jara M, Ulmer H, et al. Recipient and donor bodymass index as important risk factors for delayed kidney graft function. Transplantation. 2012;93:524-549.
15. Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant. 2006;6:357-363.
16. Chang SH,Coates PT,McDonald SP. Effects of bodymass index at transplant on outcomes of kidney transplantation. Transplantation. 2007;84:981-987.
17. Massarweh NN, Clayton JL, Mangum CA, et al. High body mass index and short-and long-term renal allograft survival in adults. Transplantation. 2005;80:1430-1434.
18. LaMattina JC, Foley DP, Fernandez LA, et al. Complications associated with liver transplantation in the obese recipient. Clin Transplant. 2012; 26:910-918.
19. Heinbokel T, Floerchinger B, Schmiderer A, et al. Obesity and its impact on transplantation and alloimmunity. Transplantation. 2013;96:10-16.
20. Collins S, Martin TL, Surwit RS, et al. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav. 2004;81:243-248.
21. Lantz O, Grandjean I,Matzinger P, et al. Gamma chain required for naive CD4 + T cell survival but not for antigen proliferation. Nat Immunol. 2000;1:54-58.
22. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 1973;16:343-350.
23. Papalia T, Greco R, Lofaro D, et al. Impact of body mass index on graft loss in normal and overweight patients: retrospective analysis of 206 renal transplants. Clin Transplant. 2010;24:E241-E246.
24. Sampaio MS, Reddy PN, Kuo HT, et al. Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant. Transplantation. 2010;89:1117-1125.
25. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002;73:70-74.
26. Meier-Kriesche HU, Vaghela M, Thambuganipalle R, et al. The effect of body mass index on long-term renal allograft survival. Transplantation. 1999;68:1294-1297.
27. Grady KL, White-Williams C, Naftel D, et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant. 1999;18:750-763.
28. Grady KL, Costanzo MR, Fisher S, et al. Preoperative obesity is associated with decreased survival after heart transplantation. J Heart Lung Transplant. 1996;15:863-871.
29. Wang B, Chandrasekera PC, Pippin JJ. Leptin-and leptin receptordeficient rodentmodels: relevance for human type 2 diabetes. Curr Diabetes Rev. 2014;10:131-145.
30. Pham PT, Danovitch GM, Pham PC. Obesity and its impact on transplantation and alloimmunity. Transplantation. 2013;96:e71-e72.
31. Kovesdy CP, Czira ME, Rudas A, et al. Body mass index, waist circumference andmortality in kidney transplant recipients. Am J Transplant. 2010; 10:2644-2651.
32. van Ree RM, de Vries AP, Oterdoom LH, et al. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. Nephrol Dial Transplant. 2005;20:2524-2531.
33. Moraes-Vieira PM, Bassi EJ, Larocca RA, et al. Leptin deficiency modulates allograft survival by favoring a Th2 and a regulatory immune profile. Am J Transplant. 2013;13:36-44.
34. Mirsoian A, Bouchlaka MN, Sckisel GD, et al. Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice. J ExpMed. 2014;211:2373-2383.
35. Winer S, Paltser G, Chan Y, et al. Obesity predisposes to Th17 bias. Eur J Immunol. 2009;39:2629-2635.
36. Erridge C, Attina T, Spickett CM, et al. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007;86:1286-1292.
37. Brandsma E, Houben T, Fu J, et al. The immunity-diet-microbiota axis in the development of metabolic syndrome. Curr Opin Lipidol. 2015;26: 73-81.
38. Zhao L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol. 2013;11:639-647.
39. Backhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915-1920.
40. Maynard CL, Elson CO, Hatton RD, et al. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 2012;489:231-241.
41. Alegre ML, Mannon RB, Mannon PJ. The microbiota, the immune system and the allograft. Am J Transplant. 2014;14:1236-1248.
42. Yuan J, Bagley J, Iacomini J. Hyperlipidemia promotes anti-donor Th17 responses that accelerate allograft rejection. Am J Transplant. 2015;15: 2336-2345.
43. Okamoto Y, Christen T, Shimizu K, et al. Adiponectin inhibits allograft rejection in murine cardiac transplantation. Transplantation. 2009;88: 879-883.
44. Shi H, Kokoeva MV, Inouye K, et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116: 3015-3025.
45. Khatri P, Roedder S, Kimura N, et al. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J ExpMed. 2013;210:2205-2221.